Related Experiment Video
Updated: Mar 8, 2026
08:02
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
10.1K
Use of topical glucocorticoids: a population-based cohort study.
M El-Khoury1, R Thay1, M N'Diaye1
1Department of Dermatology, Henri Mondor hospital, Paris, France.
Summary
Approximately 12% of the French population is prescribed topical glucocorticoids annually. General practitioners issue most prescriptions, with high-potency formulations often used for specific patient groups.
Area of Science:
- Dermatology
- Public Health
- Pharmacology
Background:
- Limited data exists on topical glucocorticoid prescription patterns in the general population.
- Understanding these patterns is crucial for public health initiatives and resource allocation.
Purpose of the Study:
- To comprehensively analyze topical glucocorticoid prescription trends in France.
- To provide an overview of their usage across the general population.
Main Methods:
- Utilized the Echantillon Généraliste de Bénéficiaires (EGB) database, a representative sample of the French population.
- Analyzed prescription data for topical glucocorticoids over a five-year period (2011-2015).
Main Results:
- Over 33% of individuals received at least one topical glucocorticoid prescription during the study period.
- Prescription prevalence increased from 11.7% in 2011 to 12.5% in 2015.
- General practitioners predominantly prescribed these medications (73.1%), with high-potency formulations frequently dispensed.
Conclusions:
- An estimated 12% of the French population is prescribed topical glucocorticoids annually.
- General practitioners are the primary prescribers, accounting for the majority of prescriptions.
- A small subset of patients received a high volume of potent topical glucocorticoids, often for dermatological conditions like psoriasis and eczema.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
588
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
588
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
196
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
196
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
302
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
302
01:06Oral Hypoglycemic Agents: Glinides
784
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
784
01:29Bias in Epidemiological Studies
1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.5K